Drug intelligence / Profile preview

Rebixiao Chinese Herbal Tablets

Development stage: Unknown
Lead developer: Chongqing City Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Rebixiao Chinese Herbal Tablets is a traditional Chinese medicine (TCM) formulation developed as a hospital preparation by the Chongqing Hospital of Traditional Chinese Medicine. It is specifically indicated for the treatment of acute gouty arthritis, particularly in patients diagnosed with the 'damp-heat accumulation' syndrome according to TCM principles. The formulation is designed to clear heat, resolve dampness, and provide anti-inflammatory and analgesic effects to alleviate the symptoms of acute gout flares. In clinical trial settings, it has been evaluated in randomized, double-blind, multicenter controlled trials to compare its efficacy and safety against standard Chinese formula granules.

Other names: Rebixiao tabletsRebixiao

Beyond the preview

Go deeper on Rebixiao Chinese Herbal Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rebixiao Chinese Herbal Tablets.

Explore the full profile